A Blood Test to Look at Cells of the Immune System in Healthy Children
Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Aug 30, 2001
Trial Information
Current as of March 19, 2025
Completed
Keywords
ClinConnect Summary
Early in life, the cells involved in immune selection differentiate into CD4+ and CD8+ cells. Currently there is insufficient information on the cell maturation and activation of these peripheral blood mononuclear cell (PBMC) subsets in normal children. The critical need for this information has been brought about by the pediatric HIV/AIDS epidemic, which requires the measurement of peripheral blood CD4+ T cells and other cells types for interpretation of HIV disease progression. The immunopathogenesis of pediatric HIV infection differs from that in adults but is not well understood. In ord...
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- A child may be eligible for this study if he/she:
- • Is 0 - 18 years old.
- • Is HIV-negative and is born to an HIV-negative mother.
- • Is healthy (no serious infection or disease).
- • Has signed informed consent of a parent or legal guardian if under 18.
- • Exclusion Criteria
- A child will not be eligible for this study if he/she:
- • Is pregnant or breast-feeding.
- • Has already completed this study once before.
- • Is taking prescription medications other than prescription vitamins.
Trial Officials
W Shearer
Study Chair
H Rosenblatt
Study Chair
About National Institute Of Allergy And Infectious Diseases (Niaid)
The National Institute of Allergy and Infectious Diseases (NIAID) is a key component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of infectious and immune-mediated diseases. Through rigorous clinical trials, NIAID aims to foster innovative research that enhances public health and addresses global health challenges, including emerging infectious diseases and allergies. The institute collaborates with various partners, including academic institutions, industry, and international organizations, to translate scientific discoveries into effective therapies and vaccines. NIAID's commitment to high-quality clinical research is integral to improving health outcomes and informing policy decisions in the realm of infectious diseases and immunology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Springfield, Massachusetts, United States
Seattle, Washington, United States
Bronx, New York, United States
La Jolla, California, United States
Los Angeles, California, United States
Los Angeles, California, United States
San Francisco, California, United States
Washington, District Of Columbia, United States
Washington, District Of Columbia, United States
Miami, Florida, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Baltimore, Maryland, United States
Boston, Massachusetts, United States
New Brunswick, New Jersey, United States
Newark, New Jersey, United States
Albany, New York, United States
Great Neck, New York, United States
New Hyde Park, New York, United States
New York, New York, United States
New York, New York, United States
Stony Brook, New York, United States
Durham, North Carolina, United States
Philadelphia, Pennsylvania, United States
Charleston, South Carolina, United States
Houston, Texas, United States
Bayamon, , Puerto Rico
San Juan, , Puerto Rico
San Juan, , Puerto Rico
Newark, New Jersey, United States
Bronx, New York, United States
New Orleans, Louisiana, United States
Worcester, Massachusetts, United States
Jacksonville, Florida, United States
Rochester, New York, United States
Birmingham, Alabama, United States
Mobile, Alabama, United States
Fort Lauderdale, Florida, United States
Riviera Beach, Florida, United States
Jackson, Mississippi, United States
Columbus, Georgia, United States
New Orleans, Louisiana, United States
Chicago, Illinois, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials